GSTA1 and metabolic dysfunction-associated steatotic liver disease: To further verify the relationship between GSTA1 and the accumulation of LD, we used hepatocytes treated with OA, free fatty acid (FFA), and palmitic acid (PA) to mimic the pathological state of MASLD in vitro.